Harrow Launches Harrow Access for All (HAFA) GlobeNewswire September 25, 2025 HAFA to Expand Harrow's Innovative Market Access Model Across Ophthalmic Portfolio Program will be available in late 2025 through the HarrowAccess.com Portal NASHVILLE, Tenn., Sept. 25, 2025 (GLOBE NEWSWIRE) — Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, […]

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire September 25, 2025 MIAMI, Sept. 25, 2025 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard(TM) Prime carotid stent system for the prevention of stroke, today announced that the Compensation Committee of InspireMD's Board of Directors approved inducement grants

Option Care Health to Announce Third Quarter 2025 Financial Results and Host Conference Call GlobeNewswire September 25, 2025 BANNOCKBURN, Ill., Sept. 25, 2025 (GLOBE NEWSWIRE) — Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results

Work can now begin to save taxpayers money and build a financially sound postal service Today's announcement by the Government of Canada will allow our country's national postal service to chart a strong, financially sustainable path forward that supports the changing needs of Canadians. Letter mail has been steadily declining for almost two decades, down

BOULDER, COLORADO / ACCESS Newswire / September 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, and animal health care, today announced that it will participate in

Learn about the best gold IRA companies 2025 in IRAEmpire’s latest rankings. NEW YORK CITY, NEW YORK / ACCESS Newswire / September 25, 2025 / Planning for retirement in 2025 looks very different than it did just a few years ago. With inflation still eating away at savings, market volatility shaking investor confidence, and global

(NASDAQ:CDTX), – Phase 3 study expected to enroll 6,000 participants starting in the Northern Hemisphere – Participants will include adults over 65 years of age in addition to individuals with high-risk co-morbidities and immune compromised status SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary

(NasdaqGM:XENE), VANCOUVER, British Columbia and BOSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced that the company will host an investor webinar focused on its early-stage programs targeting Kv7 and Nav1.7

(NASDAQ:SFHG), Hong Kong, Sept. 25, 2025 (GLOBE NEWSWIRE) — On September 24, 2025, Samfine Creation Holdings Group Limited (the “Company“) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market, LLC notifying the Company that Nasdaq has granted the Company a 180-day extension, until March 23, 2026 (the “Extension Period“), to regain

Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain GlobeNewswire September 25, 2025 VANCOUVER, British Columbia and BOSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in